Does α-synuclein modulate dopaminergic synaptic content and tone at the synapse?

被引:133
作者
Sidhu, A
Wersinger, C
Vernier, P
机构
[1] Georgetown Univ, Dept Pediat, Washington, DC USA
[2] CNRS, Inst Neurobiol Alfred FESSARD, F-91198 Gif Sur Yvette, France
关键词
dopamine transporter; Parkinson's disease; synucleopathies; neurodegeneration; MPTP; Lewy bodies;
D O I
10.1096/fj.03-1112rev
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alpha-Synuclein is a key component of the pathological process of neurodegeneration in Parkinson's disease. Although its contributions to normal physiological conditions remain elusive, converging observations suggest that a primary function of this protein in dopaminergic neurons may be the regulation of dopamine content and synaptic tone at the synapse. We review here cumulative evidence that demonstrates the participation of alpha-synuclein in the life cycle of dopamine from its synthesis, storage, release, and reuptake. The regulatory role of alpha-synuclein on dopamine metabolism is assessed by discussing the experimental evidence supporting each of these observations in the healthy physiological maintenance of dopaminergic neurons, as well as showing how disruption of these events can initiate the observed neurotoxicity of alpha-synuclein and the genesis of the degenerative processes associated with Parkinson's disease.
引用
收藏
页码:637 / 647
页数:11
相关论文
共 148 条
[41]   Are ubiquitination pathways central to Parkinson's disease? [J].
Giasson, BI ;
Lee, VMY .
CELL, 2003, 114 (01) :1-8
[42]   A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly [J].
Giasson, BI ;
Murray, IVJ ;
Trojanowski, JQ ;
Lee, VMY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (04) :2380-2386
[43]   Lewy body diseases and multiple system atrophy as α-synucleinopathies [J].
Goedert, M ;
Spillantini, MG .
MOLECULAR PSYCHIATRY, 1998, 3 (06) :462-465
[44]   Alpha-synuclein and neurodegenerative diseases [J].
Goedert, M .
NATURE REVIEWS NEUROSCIENCE, 2001, 2 (07) :492-501
[45]   Filamentous nerve cell inclusions in neurodegenerative diseases [J].
Goedert, M ;
Spillantini, MG ;
Davies, SW .
CURRENT OPINION IN NEUROBIOLOGY, 1998, 8 (05) :619-632
[46]   Is there a cause-and-effect relationship between α-synuclein fibrillization and Parkinson's disease? [J].
Goldberg, MS ;
Lansbury, PT .
NATURE CELL BIOLOGY, 2000, 2 (07) :E115-E119
[47]  
GRAHAM DG, 1978, MOL PHARMACOL, V14, P633
[48]   Oxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro [J].
Hashimoto, M ;
Hsu, LJ ;
Xia, Y ;
Takeda, A ;
Sisk, A ;
Sundsmo, M ;
Masliah, E .
NEUROREPORT, 1999, 10 (04) :717-721
[49]   α-synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells [J].
Hashimoto, M ;
Hsu, LJ ;
Rockenstein, E ;
Takenouchi, T ;
Mallory, M ;
Masliah, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :11465-11472
[50]   EVIDENCE FOR RECYCLING OF SYNAPTIC VESICLE MEMBRANE DURING TRANSMITTER RELEASE AT FROG NEUROMUSCULAR JUNCTION [J].
HEUSER, JE ;
REESE, TS .
JOURNAL OF CELL BIOLOGY, 1973, 57 (02) :315-344